Bristol-Myers Squibb Co
XBER:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
XBER:BRM
|
US |
|
Avalo Therapeutics Inc
F:C6K0
|
US |
|
C
|
Consolidated Edison Inc
DUS:EDC
|
US |
Intrinsic Value
The intrinsic value for 
Bristol-Myers Squibb Co (BRM) under the Base Case is 57.57 EUR.
Compared with the current market price of 46.07 EUR, the stock appears
Undervalued by 20% .
Both DCF and multiples point to undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Bristol-Myers Squibb Co.
Fundamental Analysis
Revenue & Expenses Breakdown
Bristol-Myers Squibb Co
Earnings Waterfall
Bristol-Myers Squibb Co
The intrinsic value for Bristol-Myers Squibb Co (BRM) under the Base Case is 57.57 EUR.
Compared with the current market price of 46.07 EUR, the stock appears Undervalued by 20% .
